标题
Demystifying the management of hypertriglyceridaemia
作者
关键词
-
出版物
Nature Reviews Cardiology
Volume 10, Issue 11, Pages 648-661
出版商
Springer Nature
发表日期
2013-09-24
DOI
10.1038/nrcardio.2013.140
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2013) Todd J. Anderson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy-Derived LDL Particle Number with Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices
- (2013) T. G. Cole et al. CLINICAL CHEMISTRY
- Statin Intolerance: Why and What to do – With a Focus on Diabetic People
- (2013) E. Matteucci et al. CURRENT MEDICINAL CHEMISTRY
- Novel Insights Into the Regulation of Postprandial Lipemia by Glucagon-Like Peptides: Significance for Diabetes
- (2013) G. F. Watts et al. DIABETES
- Factors underlying regression of coronary atheroma with potent statin therapy
- (2013) Rishi Puri et al. EUROPEAN HEART JOURNAL
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
- (2013) et al. EUROPEAN HEART JOURNAL
- Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version
- (2013) Tamio Teramoto et al. Journal of Atherosclerosis and Thrombosis
- Cardiac Steatosis Associates With Visceral Obesity in Nondiabetic Obese Men
- (2013) Marit Granér et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Using Mendelian randomization to determine causative factors in cardiovascular disease
- (2013) C. T. Johansen et al. JOURNAL OF INTERNAL MEDICINE
- Ectopic lipid storage and insulin resistance: a harmful relationship
- (2013) J. Borén et al. JOURNAL OF INTERNAL MEDICINE
- n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
- (2013) Ramón Estruch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Medical resource use and costs associated with chylomicronemia
- (2013) Daniel Gaudet et al. JOURNAL OF MEDICAL ECONOMICS
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
- (2012) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data
- (2012) Michael E Cobble et al. Cardiovascular Diabetology
- The Complex Genetic Basis of Plasma Triglycerides
- (2012) Christopher T. Johansen et al. Current Atherosclerosis Reports
- Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study
- (2012) H. Denison et al. DIABETES OBESITY & METABOLISM
- Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
- (2012) D. E. Bonds et al. DIABETOLOGIA
- Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
- (2012) Anders Berg Jørgensen et al. EUROPEAN HEART JOURNAL
- Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency
- (2012) Anthony S Wierzbicki et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
- (2012) D Gaudet et al. GENE THERAPY
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Double-Blind Randomized Clinical Trial of the Effects of Ezetimibe on Postprandial Hyperlipidaemia and Hyperglycaemia
- (2012) Kaori Kikuchi et al. Journal of Atherosclerosis and Thrombosis
- A comparison of the efficacy of combined ezetimibe and statin therapy with doubling of statin dose in patients with remnant lipoproteinemia on previous statin therapy
- (2012) Takamitsu Nakamura et al. Journal of Cardiology
- Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
- (2012) Lars Berglund et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)
- (2012) Harold E. Bays et al. Journal of Clinical Lipidology
- The DGAT1 Inhibitor LCQ908 Decreases Triglyceride Levels in Patients with the Familial Chylomicronemia Syndrome
- (2012) Charles Meyers et al. Journal of Clinical Lipidology
- Mutations inLPL,APOC2,APOA5,GPIHBP1andLMF1in patients with severe hypertriglyceridaemia
- (2012) R. P. Surendran et al. JOURNAL OF INTERNAL MEDICINE
- Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
- (2012) Philip J. Barter et al. JOURNAL OF LIPID RESEARCH
- The PCSK9 decade
- (2012) Gilles Lambert et al. JOURNAL OF LIPID RESEARCH
- Effects of Fibrates in Kidney Disease
- (2012) Min Jun et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins for people at low risk of cardiovascular disease – Authors' reply
- (2012) Borislava Mihaylova et al. LANCET
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Gut-liver interaction in triglyceride-rich lipoprotein metabolism
- (2011) Changting Xiao et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects
- (2011) Marja-Riitta Taskinen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triglycerides and Heart Disease
- (2011) Ira J. Goldberg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Ectopic Fat Depots and Cardiovascular Disease
- (2011) Kathryn A. Britton et al. CIRCULATION
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
- (2011) Genovefa D. Kolovou et al. Current Vascular Pharmacology
- Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
- (2011) B. Cariou et al. DIABETES CARE
- Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
- (2011) R. R. Wing et al. DIABETES CARE
- Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study
- (2011) L. A. Leiter et al. DIABETIC MEDICINE
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient
- (2011) G. F. Watts et al. HEART
- Proposed Guidelines for Hypertriglyceridemia in Japan with Non-HDL Cholesterol as the Second Target
- (2011) Hitoshi Shimano et al. Journal of Atherosclerosis and Thrombosis
- Diagnosis and Management of Type I and Type V Hyperlipoproteinemia
- (2011) Takanari Gotoda et al. Journal of Atherosclerosis and Thrombosis
- Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
- (2011) Michael H. Davidson et al. Journal of Clinical Lipidology
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
- (2011) Zahi A Fayad et al. LANCET
- Dynamics of human adipose lipid turnover in health and metabolic disease
- (2011) Peter Arner et al. NATURE
- Brown adipose tissue activity controls triglyceride clearance
- (2011) Alexander Bartelt et al. NATURE MEDICINE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- An update on the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design
- (2010) Robert M. Califf et al. AMERICAN HEART JOURNAL
- Treating Mixed Hyperlipidemia and the Atherogenic Lipid Phenotype for Prevention of Cardiovascular Events
- (2010) Melvyn Rubenfire et al. AMERICAN JOURNAL OF MEDICINE
- Plasma PCSK9 is increased by Fenofibrate and Atorvastatin in a non-additive fashion in diabetic patients
- (2010) P. Costet et al. ATHEROSCLEROSIS
- Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
- (2010) D. C. Chan et al. DIABETES CARE
- Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies
- (2010) Dick C Chan et al. EXPERT OPINION ON PHARMACOTHERAPY
- ‘Trig-onometry’: non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia
- (2010) T. A. Jacobson INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- When is equal not equal?
- (2010) Allan D. Sniderman et al. Journal of Clinical Lipidology
- Genetic determinants of plasma triglycerides
- (2010) Christopher T. Johansen et al. JOURNAL OF LIPID RESEARCH
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- Cardiovascular effects of marine omega-3 fatty acids
- (2010) Palaniappan Saravanan et al. LANCET
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia
- (2010) Christopher T Johansen et al. NATURE GENETICS
- Diagnosis and treatment of apolipoprotein B dyslipoproteinemias
- (2010) Allan Sniderman et al. Nature Reviews Endocrinology
- Combination Lipid Therapy in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
- (2010) M. John Chapman et al. PHARMACOLOGY & THERAPEUTICS
- Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease
- (2009) Ole Faergeman et al. AMERICAN JOURNAL OF CARDIOLOGY
- Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort
- (2009) Marcella E Rumawas et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study
- (2009) Benoit J. Arsenault et al. ATHEROSCLEROSIS
- Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
- (2009) Vivian A. Fonseca et al. DIABETES OBESITY & METABOLISM
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)
- (2009) E-Chiang Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia
- (2009) André J Tremblay et al. JOURNAL OF LIPID RESEARCH
- Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
- (2009) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
- (2009) Robert R Henry et al. LANCET
- Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness
- (2009) Allen J. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
- (2009) Frank M. Sacks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chylomicronemia and the Chylomicronemia Syndrome: A Practical Approach to Management
- (2008) David Alexander Leaf AMERICAN JOURNAL OF MEDICINE
- Leukocyte Activation by Triglyceride-Rich Lipoproteins
- (2008) Arash Alipour et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
- (2008) Martin Adiels et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- (2008) Esther M. M. Ooi et al. CLINICAL SCIENCE
- Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
- (2008) J. D. Brunzell et al. DIABETES CARE
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia
- (2008) Harold E. Bays et al. Journal of Clinical Lipidology
- Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice
- (2008) Allan D. Sniderman Journal of Clinical Lipidology
- Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials
- (2008) A. Pandor et al. JOURNAL OF INTERNAL MEDICINE
- Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation
- (2008) Limin Wang et al. JOURNAL OF LIPID RESEARCH
- Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes
- (2008) Jerome L. Fleg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial
- (2008) Michael Miller et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins and diabetes – Authors' reply
- (2008) Patricia M Kearney et al. LANCET
- Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
- (2008) Anne B. Rossebø et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analyses of Cancer Data from Three Ezetimibe Trials
- (2008) Richard Peto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
- (2008) John J.P. Kastelein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
- (2008) Iris Shai et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
- (2008) W. Kim et al. PHARMACOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started